Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interstitial cystitis.

John W Warren1, Susan K Keay

  • 1Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. jwarren@medicine.umaryland.edu

Current Opinion in Urology
|December 26, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prodrome and Non-prodrome Phenotypes of Bladder Pain Syndrome/Interstitial Cystitis.

Urology·2018
Same author

Glycoamino Acid Analogues of the Thomsen-Friedenreich Tumor-Associated Carbohydrate Antigen: Synthesis and Evaluation of Novel Antiproliferative Factor Glycopeptides.

ACS omega·2017
Same author

Death-associated Protein Kinase-1 Expression and Autophagy in Chronic Lymphocytic Leukemia Are Dependent on Activating Transcription Factor-6 and CCAAT/Enhancer-binding Protein-β.

The Journal of biological chemistry·2016
Same author

Editorial Comment.

The Journal of urology·2016
Same author

Varicella-Zoster Virus Vasculopathy: A Case Report Demonstrating Vasculitis using Black-Blood MRI.

Journal of neurology & neurophysiology·2016
Same author

Abnormal Akt signalling in bladder epithelial cell explants from patients with interstitial cystitis/bladder pain syndrome can be induced by antiproliferative factor treatment of normal bladder cells.

BJU international·2016
Same journal

Role and relevance of genetic testing in patients with kidney stones: a review from EAU Section of Endourology.

Current opinion in urology·2026
Same journal

Advances in evaluating and delivering nontechnical skills training: The use of simulation, robotics, artificial intelligence and virtual reality.

Current opinion in urology·2026
Same journal

Educating for a sustainable future: faculty and student perspectives and a review of environmental sustainability in medical education - an EAU endourology study.

Current opinion in urology·2026
Same journal

Shaping the future of endourology: role of education, simulation and uro-technology: a scoping review by the EAU Section of Endourology.

Current opinion in urology·2026
Same journal

A review of emerging technologies and techniques for percutaneous nephrolithotomy access.

Current opinion in urology·2026
Same journal

Artificial intelligence in kidney cancer: a review of clinical applications across the disease spectrum.

Current opinion in urology·2026
See all related articles

Diagnosing interstitial cystitis is challenging, but promising noninvasive markers may soon aid in diagnosis and understanding the disease. Current treatments for interstitial cystitis are still based on empirical evidence.

Area of Science:

  • Urology
  • Nephrology
  • Immunology

Background:

  • Interstitial cystitis (IC) diagnosis lacks standardized methods.
  • Current diagnostic approaches for IC are often invasive and inconclusive.
  • Understanding IC pathogenesis is crucial for developing targeted therapies.

Purpose of the Study:

  • To review potential noninvasive diagnostic markers for interstitial cystitis.
  • To explore how these markers may elucidate the underlying pathogenesis of IC.
  • To highlight the current limitations in IC treatment.

Main Methods:

  • Literature review of studies on interstitial cystitis diagnostic markers.
  • Analysis of research on potential biomarkers for IC.
  • Synthesis of current understanding of IC pathogenesis and treatment.

Related Experiment Videos

Main Results:

  • Several promising markers for interstitial cystitis have been identified.
  • These markers may offer a noninvasive route for IC diagnosis.
  • Biomarkers could provide insights into the mechanisms driving IC.

Conclusions:

  • Noninvasive diagnostic markers show potential for improving interstitial cystitis diagnosis.
  • Further research is needed to validate these markers and understand IC pathogenesis.
  • Empiric treatment strategies for interstitial cystitis remain the current standard.